Evaluation of maternal serum dimeric inhibin a as a first‐trimester marker of down's syndrome

作者: E. M. Wallace , V. E. Grant , I. A. Swanston , N. P. Groome

DOI: 10.1002/PD.1970150410

关键词:

摘要: While second-trimester prenatal screening programmes for Down's syndrome have become established in care, it would be advantageous to able offer earlier preganancy. To this end, we evaluated a new potential maternal serum marker, dimeric inhibin A, as possible first-trimester marker. Dimeric A was measured propsectively collected from 23 cases of and matched chromosomally normal controls, at 11–13 weeks' gestation. Levels protein were significantly elevated the pregnancies compared with control pregnancies. The median multiple (MOM) samples 2.46 (95 per cent confidence interval: 2.11–3.26, P<0.0001 vs. controls). These results suggest that is useful discriminator Down's-affected first trimester sensitive combination age other markers may practicable trimester.

参考文章(12)
Nigel Groome, Martin O'Brien, Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. Journal of Immunological Methods. ,vol. 165, pp. 167- 176 ,(1993) , 10.1016/0022-1759(93)90342-5
MCM Macintosh, T Chard, Biochemical screening for Down’s syndrome in the first trimester of pregnancy Fetal and Maternal Medicine Review. ,vol. 5, pp. 181- 190 ,(1993) , 10.1017/S0965539500000875
Euan M. Wallace, Linda M. Harkness, Sheila Burns, William A. Liston, Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome Clinical Endocrinology. ,vol. 41, pp. 483- 486 ,(1994) , 10.1111/J.1365-2265.1994.TB02579.X
N. P. Groome, P. J. Illingworth, M. O'Brien, I Cooke, T. S. Ganesan, D. T. Baird, A. S. McNeilly, Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clinical Endocrinology. ,vol. 40, pp. 717- 723 ,(1994) , 10.1111/J.1365-2265.1994.TB02504.X
K Spencer, J.N Macri, D.A Aitken, J.M Connor, Free β-hCG as first-trimester marker for fetal trisomy The Lancet. ,vol. 339, pp. 1480- ,(1992) , 10.1016/0140-6736(92)92073-O
S. Tovanabutra, P. J. Illingworth, W. L. Ledger, A. F. Glasier, D. T. Baird, The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy Clinical Endocrinology. ,vol. 38, pp. 101- 107 ,(1993) , 10.1111/J.1365-2265.1993.TB00979.X
ALAN L. SCHNEYER, ANTHONY J. MASON, LOUIS E. BURTON, JAY R. ZIEGNER, WILLIAM F. CROWLEY, Immunoreactive inhibin α-subunit in human serum: implications for radioimmunoassay The Journal of Clinical Endocrinology and Metabolism. ,vol. 70, pp. 1208- 1212 ,(1990) , 10.1210/JCEM-70-4-1208
Y. ABE, Y. HASEGAWA, K. MIYAMOTO, M. YAMAGUCHI, A. ANDOH, Y. IBUKI, M. IGARASHI, High Concentrations of Plasma Immunoreactive Inhibin during Normal Pregnancy in Women The Journal of Clinical Endocrinology and Metabolism. ,vol. 71, pp. 133- 137 ,(1990) , 10.1210/JCEM-71-1-133
J. M. M. Van Lith, J. J. Pratt, J. R. Beekhuis, A. Mantingh, Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenatal Diagnosis. ,vol. 12, pp. 801- 806 ,(1992) , 10.1002/PD.1970121005
H. S. Cuckle, S. Holding, R. Jones, Maternal serum inhibin levels in second-trimester down's syndrome pregnancies Prenatal Diagnosis. ,vol. 14, pp. 387- 390 ,(1994) , 10.1002/PD.1970140508